This suggests that in CML cells, the occurrence of ferroptosis may require the coordinated regulation of the two antioxidant defense systems, TXNRD1 and GSH/GPX4. This evidence concerns the gene TXNRD1 and chronic myelogenous leukemia, BCR-ABL1 positive.